Repligen Corporation (RGEN)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$133.07
+1.05%
Mkt Cap $7.34B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (18 analysts)
$183.00
Range $160.00 – $200.00
Implied Upside
+37.5%
Consensus $183.00 vs current $133.07